Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-09 10:01 am Purchase | 13G | VERVE THERAPEUTICS INC VERV | FMR LLC | 5,001,482 10.382% | 159,757 (+3.30%) | View |
| 2022-02-04 09:24 am Purchase | 13G | VERVE THERAPEUTICS INC VERV | WELLINGTON MANAGEMENT GROUP LLP | 3,939,508 8.18% | 3,939,508 (New Position) | View |
| 2022-02-04 08:53 am Sale | 13G | VERVE THERAPEUTICS INC VERV | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 1,871,679 3.89% | -623,892 (-25.00%) | View |
| 2022-01-24 08:22 am Purchase | 13G | VERVE THERAPEUTICS INC VERV | SINGER JAMES R | 2,465,000 5.1% | 2,465,000 (New Position) | View |
| 2021-12-28 12:05 pm Purchase | 13G | VERVE THERAPEUTICS INC VERV | FMR LLC | 4,841,725 10.051% | 1,522,263 (+45.86%) | View |
| 2021-06-28 08:50 am Purchase | 13G | VERVE THERAPEUTICS INC VERV | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 2,495,571 5.18% | 2,495,571 (New Position) | View |
| 2021-06-23 11:38 am Purchase | 13G | VERVE THERAPEUTICS INC VERV | Casdin Capital LLC | 3,038,167 6.6% | 3,038,167 (New Position) | View |
| 2021-06-23 11:08 am Purchase | 13G | VERVE THERAPEUTICS INC VERV | FMR LLC | 3,319,462 7.198% | 3,319,462 (New Position) | View |